Back to Walleye Capital LLC Walleye Capital LLC

IOVAIOVA

Showing 7 of 18 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in IOVANCE BIOTHERAPEUTICS INC

Yes. Walleye Capital holds 217 shares of IOVA (Iovance Biotherapeutics), worth $903, as of its Q2 2026 13F filing. It reduced the position by 30,139 shares (-99.3%) from Q1 2026. Walleye Capital has held IOVA since Q3 2025, across 4 quarterly 13F filings.

Current Value

$903

Current Shares

217

Total Value Change

-$127,411

Total Shares Change

-13,448

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
217
-99.3%
$9030.0%$4.16
0
2026-Q1
Decreased
30,356
-96.3%
$106,5500.0%$3.51
0
2025-Q4
Increased
822,754
+2143.2%
$2.2M0.0%$2.73
42
2025-Q3
New
36,677
—
$79,5890.0%$2.17
30
2025-Q1
Exited
0
-100.0%
$00.0%$3.33
0
2024-Q4
Increased
35,235
+157.8%
$260,7390.0%$7.40
37
2024-Q3
Decreased
13,665
-21.1%
$128,3140.0%$9.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used